Corporate Synergies is a national employee benefits and property and casualty insurance brokerage and consulting firm. We deliver strategies that control costs, relieve administrative burdens and mitigate risk. We develop a deeper understanding through established listening posts in all areas of our competencies, fueling our ability to better execute. We have won numerous awards and are recognized for our level of service and innovative programs. Corporate Synergies has also been designated as a Business Journal “Top Places to Work” company.
We operate nationally from five U.S. locations, including our headquarters in Camden, New Jersey; and regional offices in New York City; Melville, New York; Bethesda, Maryland; and Orlando, Florida.
For more information visit www.corpsyn.com or call 1.877.426.7779.
We operate nationally from five U.S. locations, including our headquarters in Camden, New Jersey; and regional offices in New York City; Melville, New York; Bethesda, Maryland; and Orlando, Florida.
For more information visit www.corpsyn.com or call 1.877.426.7779.
Location: United States
Employees: 201-500
Phone: +1 877-426-7779
Founded date: 2003
Investors 1
| Date | Name | Website |
| 03.08.2021 | Synetro Gr... | synetro.co... |
Mentions in press and media 5
| Date | Title | Description |
| 02.11.2025 | Where the blockbuster weight loss drug market stands today — and what’s coming next | The blockbuster weight loss drug market is entering a new chapter of growth. Eli Lilly and Novo Nordisk are both focused on fighting for market share, ramping up supply, testing new uses for their medicines and bringing the next wave of obe... |
| 08.11.2022 | Is retention or recruitment your top priority heading into 2023? Start with these benefits | It’s getting to be that time of year. With Thanksgiving and winter holiday breaks ahead, we’re in the final stretch of doing business in 2022. And when bonuses start getting paid out in the new year, there’s one thing that’s certain, accord... |
| 09.02.2016 | Morning Read: Performance-based prices for drugs are emerging, at least now for Novartis | LIFE SCIENCES Dune Medical Devices Ltd., a medical device company, announced the appointment of Lori Chmura as President of Dune, Inc. the Company’s US division, to lead a major corporate expansion initiative. — Dune Medical Bio-Rad Laborat... |
| - | Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet | The blockbuster weight loss drug Wegovy is now approved in the U.S. for heart health. But some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budget... |
| - | Morning Read: Performance-based prices for drugs are emerging, at least now for Novartis | TOP STORIES Insurers Cigna Corp and Aetna have struck deals with Novartis AG for a performance-based price for the Swiss drugmaker’s new heart drug, Entresto. The agreements are among the few performance-based deals that have been made publ... |